
A cross-trial comparison shows Novo's oral semaglutide produced 3.2 percentage points more weight loss than Foundayo, with Eli Lilly's drug seeing significantly higher dropout rates due to side effects.







Join 500,000+ readers who start their day with Quartz.
By subscribing, you agree to our Terms of Service and Privacy Policy.